TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation

Nature Communications

Volumn 6, Issue , 2015, Pages

  Ferri, Federica ^a,b,c,d,e,f   Parcelier, Aude ^a,b,c,d,e   Petit, Vanessa ^a,b,c,d,e   Gallouet, Anne Sophie ^a,b,c,d,e   Lewandowski, Daniel ^a,b,c,d,e   Dalloz, Marion ^a,b,c,d,e   Van Den Heuvel, Anita ^g   Kolovos, Petros ^g   Soler, Eric ^a,b,c,d,g   Squadrito, Mario Leonardo ^h   De Palma, Michele ^h   Davidson, Irwin ^f   Rousselet, Germain ^a,b,c,d,e   Romeo, Paul Henri ^a,b,c,d,e  

^a INSTITUT DE RADIOBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e Equipe Labellisée Ligue Contre le Cancer   (France)

^f INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; E1A ASSOCIATED P300 PROTEIN; ENHANCEOSOME; LIPOPOLYSACCHARIDE; TRIPARTITE MOTIF PROTEIN 33; UNCLASSIFIED DRUG; BETA INTERFERON; TRANSCRIPTION FACTOR; TRIM33 PROTEIN, MOUSE;

BACTERIAL DISEASE; GENE EXPRESSION; INFECTIVITY; VIRAL DISEASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CHROMATIN; CHROMATIN STRUCTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PROTEIN FAMILY; STABLE EXPRESSION; TRANSCRIPTION INITIATION SITE; ANIMAL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

BACTERIA (MICROORGANISMS);

ANIMALS; FEMALE; GENE EXPRESSION REGULATION; INTERFERON-BETA; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84947938347     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9900     Document Type: Article

References (43)

1. Trinchieri, G. Type I interferon: friend or foe? J. Exp. Med. 207, 2053-2063 (2010).
2. Stetson, D. B. & Medzhitov, R. Type I interferons in host defense. Immunity 25, 373-381 (2006).
3. Teijaro, J. R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207-211 (2013).
4. Wilson, E. B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202-207 (2013).
5. Ford, E. & Thanos, D. The transcriptional code of human IFN-beta gene expression. Biochim. Biophys. Acta. 1799, 328-336 (2010).
6. Li, P. et al. IRF8 and IRF3 cooperatively regulate rapid interferon-beta induction in human blood monocytes. Blood 117, 2847-2854 (2011).
7. Kim, H. & Seed, B. The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3. Nat. Immunol. 11, 743-750 (2010).
8. Siednienko, J. et al. Nuclear factor kappaB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated beta-interferon production via induction of transcriptional repressor protein YY1. J. Biol. Chem. 286, 44750-44763 (2011).
9. Josse, T. et al. Association of the interferon-beta gene with pericentromeric heterochromatin is dynamically regulated during virus infection through a YY1-dependent mechanism. Nucleic. Acids. Res. 40, 4396-4411 (2012).
10. Weill, L., Shestakova, E. & Bonnefoy, E. Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. J. Virol. 77, 2903-2914 (2003).
11. Hatakeyama, S. TRIM proteins and cancer. Nat. Rev. Cancer 11, 792-804 (2011).
12. Herquel, B., Ouararhni, K. & Davidson, I. The TIF1alpha-related TRIM cofactors couple chromatin modifications to transcriptional regulation, signaling and tumor suppression. Transcription 2, 231-236 (2011).
13. Herquel, B. et al. Trim24-repressed VL30 retrotransposons regulate gene expression by producing noncoding RNA. Nat. Struct. Mol. Biol. 20, 339-346 (2013).
14. Xi, Q. et al. A poised chromatin platform for TGF-beta access to master regulators. Cell 147, 1511-1524 (2011).
15. Kusy, S. et al. Adult hematopoiesis is regulated by TIF1gamma, a repressor of TAL1 and PU.1 transcriptional activity. Cell Stem Cell 8, 412-425 (2011).
16. Bai, X. et al. TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell 142, 133-143 (2010).
17. Ozato, K., Shin, D. M., Chang, T. H. & Morse, 3rd H. C. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8, 849-860 (2008).
18. McNab, F. W., Rajsbaum, R., Stoye, J. P. & O'Garra, A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 23, 46-56 (2011).
19. Tisserand, J. et al. Tripartite motif 24 (Trim24/Tif1 alpha) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor alpha (Rar alpha) inhibition. J. Biol. Chem. 286, 33369-33379 (2011).
20. Weng, L. et al. The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation. J. Immunol. 193, 3676-3682 (2014).
21. Squadrito, M. L. et al. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep. 8, 1432-1446 (2014).
22. Banerjee, A. R., Kim, Y. J. & Kim, T. H. A novel virus-inducible enhancer of the interferon-beta gene with tightly linked promoter and enhancer activities. Nucleic Acids Res. 42, 12537-12554 (2014).
23. Uhlenhaut, N. H. et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol. Cell 49, 158-171 (2013).
24. Lara-Astiaso, D. et al. Immunogenetics. Chromatin state dynamics during blood formation. Science 345, 943-949 (2014).
25. Bowers, E. M. et al. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem. Biol. 17, 471-482 (2010).
26. Ng, C. T. et al. Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection. Cell Host Microbe 17, 653-661 (2015).
27. Hogner, K. et al. Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 9, e1003188 (2013).
28. Ghavi-Helm, Y. et al. Enhancer loops appear stable during development and are associated with paused polymerase. Nature 512, 96-100 (2014).
29. Jin, F. et al. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 503, 290-294 (2013).
30. Pattanayak, V., Guilinger, J. P. & Liu, D. R. Determining the specificities of TALENs, Cas9, and other genome-editing enzymes. Methods Enzymol. 546, 47-78 (2014).
31. Wang, X. et al. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat. Biotechnol. 33, 175-178 (2015).
32. Kim, S., Kim, D., Cho, S. W., Kim, J. & Kim, J. S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 24, 1012-1019 (2014).
33. Mancino, A. et al. A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages. Genes Dev. 29, 394-408 (2015).
34. Rajsbaum, R. et al. Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKepsilon kinase-mediated antiviral response. Immunity 40, 880-895 (2014).
35. Inn, K. S. et al. Linear ubiquitin assembly complex negatively regulates RIG-I-and TRIM25-mediated type I interferon induction. Mol. Cell 41, 354-365 (2011).
36. Higgs, R. et al. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 181, 1780-1786 (2008).
37. Tsuchida, T. et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33, 765-776 (2010).
38. Merika, M., Williams, A. J., Chen, G., Collins, T. & Thanos, D. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol. Cell 1, 277-287 (1998).
39. Yamamoto, H., Kihara-Negishi, F., Yamada, T., Hashimoto, Y. & Oikawa, T. Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP. Oncogene 18, 1495-1501 (1999).
40. Bai, Y., Srinivasan, L., Perkins, L. & Atchison, M. L. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. J. Immunol. 175, 5160-5169 (2005).
41. Stadhouders, R. et al. Multiplexed chromosome conformation capture sequencing for rapid genome-scale high-resolution detection of long-range chromatin interactions. Nat. Protoc. 8, 509-524 (2013).
42. Kusy, S. et al. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia. J. Exp. Med. 207, 2141-2156 (2010).
43. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).